Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE: Safety Overview

Metric ERTAPENEM ERTUGLIFLOZIN PIDOLATE
Total FAERS Reports 4,069 681
Deaths Reported 223 4
Death Rate 5.5% 0.6%
Hospitalizations 1,617 128
Average Patient Age 64.1 yrs 57.0 yrs
% Female Patients 54.5% 56.1%
FDA Approval Date Apr 16, 2018 N/A
Manufacturer Merck Sharp & Dohme LLC Merck Sharp & Dohme LLC
Route INTRAMUSCULAR ORAL
Marketing Status Prescription N/A